AnPac Bio-Medical Science Co., Ltd. (ANPC) Reports Q1 Loss of $0.39

AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) reported Q1 EPS of ($0.39), versus $0.00 reported last year. Revenue for the quarter came in at $1.75 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on AnPac Bio-Medical Science Co., Ltd. (ANPC) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
• Deutsche Bank monitors UK auto sales as Chinese exports grow